H. Yahara, Megumi
Sakamoto, Toshiko
Maeda, Kazuhisa
Kinoshita, Atsushi
Ikeda, Kenji
Article History
Received: 13 April 2024
Accepted: 17 July 2025
First Online: 19 August 2025
Declarations
:
: This study was conducted in accordance with the declaration of Helsinki and the ethical guidelines for medical research involving human subjects and was approved by the Ethics Review Committee of the Osaka University Graduate School of Pharmaceutical Sciences (approval number: Yakuhito2021-13-1). Informed consent was waived by the Ethics Review Committee of the Osaka University Graduate School of Pharmaceutical Sciences (approval number: Yakuhito2021-13-1). Permission to conduct the study was obtained from the president of Hyogo Medical University (research project number: 4375). An explicit opt-out was provided to patients, disclosing information about the research and guaranteeing an opportunity for further refusal.
: Not applicable.
: The authors declare no competing interests.